UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal ...

A UAB study validates a rigorous expert panel method as a reliable gold standard for measuring delirium severity in patients with and without dementia, supporting future clinical tools and advancing ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

UAB Hospital is now the nation’s fifth‑largest hospital, delivering record patient care and expanding with new rehab, emergency and specialty facilities while leading Alabama in trauma, cancer, ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

The University of Alabama at Birmingham’s telehealth division, UAB eMedicine, has recently launched its Online Second Opinion platform. UAB eMedicine’s Online Second Opinion service allows for non-UAB ...

UAB surgeons have completed Alabama’s first living-donor liver transplant, expanding lifesaving options for patients facing ...

UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...

For physicians in Ethiopia, the partnership with UAB has significantly improved their turnaround time for CT reports, helping ...

In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of ...